Neuropsychological impairment and gender differences in HIV-1 infection

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 5, 2008, Pages 494-502

  Faílde Garrido, José M ^a   Alvarez, Marina Rodríguez ^b   Simón López, Miguel A ^c  

^a UNIVERSITY OF VIGO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

AIDS; Gender differences; HIV infection; Neuropsychological assessment; Neuropsychological impairment

Indexed keywords

ADULT; ARTICLE; ATTENTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTELLECTUAL IMPAIRMENT; INTELLIGENCE; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PSYCHOMOTOR PERFORMANCE; SEX DIFFERENCE; TASK PERFORMANCE;

ADULT; AIDS DEMENTIA COMPLEX; ATTENTION; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; INTELLIGENCE; MALE; MENTAL RECALL; NEUROPSYCHOLOGICAL TESTS; PROBLEM SOLVING; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; REPRODUCIBILITY OF RESULTS; SEX FACTORS;

EID: 53149145720     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2008.01841.x     Document Type: Article

References (60)

1. McArthur JC. Neurological and neuropathological manifestations of HIV infection. In : Grant I, Martin A (eds). Neuropsychology of HIV Infection. Oxford University Press, New York, 1994 56 107.
2. Brew B, Rosenblum M, Price RW. Complicaciones de las infecciones por VIH y del SIDA sobre el sistema nervioso central y periférico. In : de Vita VT, Hellman S, Rosenberg SA (eds). SIDA: Etiología, Diagnóstico, Tratamiento y Prevención. Salvat, Barcelona, 1990 187 199 (in Spanish).
3. Everall IP, Luthbert PJ, Lantos PL. Neuronal loss in frontal cortex in HIV infection. Lancet 1991 337 : 1119 1121.
4. Martin A. HIV cognition, and the basal ganglia. In : Grant I, Martin A (eds). Neuropsychology of HIV Infection. Oxford University Press, New York, 1994 234 259.
5. Ellis RJ, Deutsch R, Heaton RK et al. Neurocognitive impairment is an independent risk factor for death in HIV infection. Arch. Neurol. 1997 54 : 416 424.
6. Goodkin K, Wilkie FL, Concha M et al. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates. Neuroimaging Clin. N. Am. 1997 7 : 561 579.
7. White DA, Heaton RK, Monsch AU. Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. J. Int. Neuropsychol. Soc. 1995 1 : 305 315.
8. Mann J, Chin J, Piot P, Quinn T. The international epidemiology of AIDS. Sci. Am. 1988 259 : 82 89.
9. Piot P, Plummer FA, Mhalu FS, Lamboray JI, Chin J, Mann JM. AIDS: An international perspective. Science 1988 239 : 573 579.
10. Mason KJ, Campbell A, Hawkins P, Madhere S, Johnson K, Takushi-Chinen R. Neuropsychological functioning in HIV positive African American women with a history of drug use. J. Natl Med. Assoc. 1998 90 : 665 674.
11. Vázquez-Justo E, Rodríguez Alvarez M, Carro Ramos J. Neuropsychological performance in HIV/AIDS intravenous drug users. J. Clin. Exp. Neuropsychol. 2003 25 : 852 865.
12. Mastroianni AC, Faden R, Federman D. Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies. Academy Press, Washington, DC, 1994.
13. Merkatz RB, Temple R, Sobel S, Feiden K, Kessler DA. Women in clinical trials of new drugs. A change in food and drug administration policy. N. Engl. J. Med. 1993 329 : 292 296.
14. Bird CE. Women's representation as subjects in clinical studies: A pilot study of research published in JAMA in 1990 and 1992. In : Mastroianni AC, Faden R, Federman D (eds). Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies. National Academy Press, Washington, DC, 1994 151 173.
15. European Center for the Epidemiological Monitoring of AIDS. HIV/AIDS Surveillance in Europe: 1994-1996. European Centre for the Epidemiological Monitoring of AIDS, Saint-Maurice, 1996.
16. Fox-Tierney RA, Ickovics JR, Cerreta CL, Ethier KA. Potential sex differences remain understudied: A case study of the inclusion of women in HIV/AIDS-related neuropsychological research. Rev. Gen. Psychiatry 1999 3 : 44 54.
17. López OL, Wess J, Sanchez J, Dew MA, Becker JT. Neurological characteristics of HIV-infected men and women seeking primary medical care. Eur. J. Neurol. 1999 6 : 205 209.
18. Starace F, Baldassarre C, Biancolilli V et al. Early neuropsychological impairment in HIV-seropositive intravenous drug users: Evidence from the Italian multicentre neuropsychological study. Acta Neurol. Scand. 1998 97 : 132 138.
19. Durvasula RS, Miller EN, Myers HF, Wyatt GE. Predictors of neuropsychological performance in HIV positive women. J. Clin. Exp. Neuropsychol. 2001 23 : 149 163.
20. Stern RA, Silva SG, Chaisson N, Evans DI. Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Arch. Neurol. Chicago 1996 53 : 148 153.
21. Vázquez-Justo E, Rodríguez Álvarez M. Influencia de factores no relacionados con la infección en el rendimiento neuropsicológico de seropositivos al VIH. Rev. Neurol. 2002 35 : 474 480 (in Spanish).
22. Becker JT, Caldararo R, Lopez OL, Dew MA, Dorst SK, Banks G. Qualitative features of the memory deficit associated with HIV infection and AIDS: Cross-validation of a discriminant function classification scheme. J. Clin. Exp. Neuropsychol. 1995 17 : 134 142.
23. Arruda JE, Stern RA, Somerville JA, Cohen R, Stein MI, Martin EM. Neurobehavioral functioning in asymptomatic HIV-1 infected women: Preliminary findings (abstract). J. Int. Neuropsychol. Soc. 1997 3 : 14.
24. Stern RA, Arruda JE, Somerville JA et al. Neurobehavioral functioning in asymptomatic HIV-1 infected women. J. Int. Neuropsychol. Soc. 1997 4 : 172 178.
25. Hafner H, Maurer K, Loffler W et al. The epidemiology of early schizophrenia: Influence of age and gender on onset and early course. Br. J. Psychiatry 1994 164 : 29 38.
26. Kimura D. Sex differences in the brain. Sci. Am. 1992 261 : 119 125.
27. Hamilton JA. An overview of the clinical rationale for advancing gender-related psychopharmacology and drug abuse research. In : Ray BA, Braude MC (eds). Women and Drugs: A New Era for Research (National Institute on Drug Abuse Monograph). US Government Printing Office, Washington, DC, 1986 14 20.
28. Hampson E. Variations in sex-related cognitive abilities across the menstrual cycle. Brain Cogn. 1990 14 : 26 43.
29. Metsch IR, Clyde BM, Shenghan I, Heather AM. Continuing risk behaviours of HIV positive women. In : Abdool Karin Q, Abdullah AS, Abeyewinckreme I, Abrams J, Abrams DI, Abrams EJ (eds). 12th World AIDS Conference Record; 28 Jun-3 Jul 1998, Geneva, Switzerland. Marathon Multimedia, Amsterdam, 1998; 433 (abstract no. 23457).
30. Wechberg W, Dennis ML, Rach RF, Perritt R, Rodman NF, Coleman E. Does comorbidity affect HIV risk reduction outcomes among women substance abusers in the southeast united states? In : Abdool Karin Q, Abdullah AS, Abeyewinckreme I, Abrams J, Abrams DI, Abrams EJ (eds). 12th World AIDS Conference Record; 28 Jun-3 Jul 1998, Geneva, Switzerland. Marathon Multimedia, Amsterdam, 1998; 431 (abstract no. 23446).
31. Ickovics J, Rodin J. Women and AIDS in the United States: Epidemiology, natural history, and mediating mechanisms. Health Psychol. 1992 11 : 1 16.
32. Melnick SL, Sherer R, Llouis TA et al. Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn community programs for clinical research on aids. JAMA 1994 272 : 1915 1921.
33. Satz P, Morgenstern H, Miller EN et al. Low education as a possible risk factor for cognitive abnormalities in HIV-1: Findings from the multicenter AIDS cohort study (MACS). J. Acquir. Immun. Defic. Syndr. 1993 6 : 503 511.
34. Pereda M, Ayuso JL, Gómez del Barrio A et al. Factors associated with neuropsychological performance in HIV seropositive subjects without AIDS. Psychol. Med. 2000 30 : 205 217.
35. Pirolli AJ. A comparison of HIV+ men and women: Neuropsychological findings and psychological co-factors. Dissertation Abstracts Int. (B) 1997 58 : 2695.
36. Rabkin JG, Ferrando SJ, Van Gorp W, Rieppi R, McElhiney M, Sewel M. Relationships among apathy, depression, and cognitive impairment in HIV/AIDS. J. Neuropsychiatry Clin. Neurosci. 2000 12 : 451 457.
37. Grant J, Heaton RK. Human immunodeficiency virus-type 1 (HIV-1) and the brain. J. Consult. Clin. Psychol. 1990 58 : 22 30.
38. Heaton RK, Grant J, Butters N et al. The HNRC 500: Neuropsychology of HIV infection at different disease stages. J. Int. Neuropsychol. Soc. 1995 1 : 231 251.
39. Van Gorp WG, Hinking C, Satz P, Miller E, D'elia L. Neuropsychological findings in HIV infection, encephalopathy, and dementia. In : Parks R, Zec R, Wilson R (eds). Alzheimer's Disease and Related Dementias. Oxford University Press, New York, 1993 153 185.
40. Centers for Disease Control and Prevention. Revised classification system for HIV infection and expander surveillance case definition for aids among adolescents and adults. Morb. Mortal. Wkly Rep. 1992 41 : 1 19.
41. Reitan RM, Trail Making T. Manual for Administration and Scoring. Reitan Neuropsychology Laboratory, Tucson, 1992.
42. a edn. TEA, Madrid, 1986 (in Spanish).
43. Babcock H. An experiment in the measurement of mental impairment. Arch. Psychol. 1930 28 : 1 105 (in French).
44. Rey A. Test de Copia de una Figura Compleja. TEA, Madrid, 1987 (in Spanish).
45. Benton AL. Test de Retención Visual de Benton. TEA, Madrid, 1986 (in Spanish).
46. Rey A. L'examen clinique en psychologie. Presses Universitaires de France, Paris, 1964 (in French).
47. Wechsler D. Escala de Inteligencia de Wechsler para Adultos. TEA, Madrid, 1995 (in Spanish).
48. Olfield RC. The assessment and analysis of handedness: The Edinburgh Inventory. Neuropsychologia 1971 9 : 97 113.
49. Bornstein RA. Methodological and conceptual issues in the study of cognitive change in HIV infection. In : Grant I, Martin A (eds). Neuropsychology of HIV Infection. Oxford University Press, New York, 1994 146 160.
50. Marder K, Stern Y, Malouf R et al. Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome. Arch. Neurol. 1992 49 : 1169 1175.
51. Wellman MC. Neuropsychological impairment among intravenous drug users in pre-aids stages of HIV infection. Int. J. Neurosci. 1992 64 : 183 194.
52. Heseltine PNR, Goodkin K, Atkinson JH et al. Randomized double-blind placebo-controlled trial of peptide t for HIV-associated cognitive impairment. Arch. Neurol. Chicago 1998 55 : 41 51.
53. Rodríguez Salgado D, Rodríguez Álvarez M, Seoane Pesqueira G. Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users. Cogn. Behav Neurol. 2006 19 : 95 104.
54. Newman SP, Lunn S, Harrison JG. Do asymptomatic HIV-seropositive individuals show cognitive deficit? AIDS 1995 9 : 1211 1220.
55. Miller EN, Selnes OA, McArthur JC et al. Neuropsychological performance in HIV-infected homosexual men: The Multicenter AIDS Cohort Study (MACS). Neurology 1990 40 : 197 203.
56. Grant J, Atkinson JH, Hesselink JR et al. Evidence of early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Ann. Intern. Med. 1987 107 : 828 836.
57. Bix BC, Glosser G, Holmes W et al. Relationship between psychiatric disease and neuropsychological impairment in HIV seropositive individuals. J. Int. Neuropsychol. Soc. 1995 1 : 581 588.
58. Farinpour R, Martin EM, Seindenberg M et al. Verbal working memory in HIV-seropositive drug users. J. Int. Neuropsychol. Soc. 2000 6 : 548 555.
59. Villa G, Monteleone D, Marra C et al. Neuropsychological abnormalities in AIDS and asymptomatic HIV seropositive patients. J. Neurol. Neurosurg. Psychiatry 1993 56 : 878 884.
60. Baldeweg T, Catalan J, Pugh K et al. Neuropsychological changes associated with psychiatric symptoms in HIV infected individuals without aids. Biol. Psychiatry 1997 41 : 474 487.